Varex Imaging Corporation

VREXNASDAQHealthcare● Active

$10.33

+$0.24(+2.33%)

Market Cap$434682500

P/E Ratio—

52W High$14.565

52W Low$6.76

Avg Volume366K

Open$10.22

Beta0.90

Free Cash Flow Financials Revenue

Varex Imaging Corporation (VREX) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

VREX · free cash flow · updated Jun 8, 2026

Core FCF metrics

VREX · FCF · TTM · margin & CAGR

Free cash flow was $18.8M for FY2025 (fiscal year ending 2025-10-03), down 7.8% year-over-year The FCF margin was 2.2%.

FY2025 Free Cash Flow$18.8M▼ -7.8% YoY

Trailing 12M (TTM)−$30.8MTrailing 4Q sum · TTM negative vs latest FY positive

FCF Margin2.2%$18.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

VREX · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$41.7M(23M)$18.8M▼ 7.8%2.2%

FY2024$47.3M(27M)$20.4M▼ 76.7%2.5%

FY2023$108.4M(21M)$87.7M▲ +2093.2%9.8%

FY2022$16.9M(21M)−$4.4M▼ 105.7%-0.5%

FY2021$92.6M(15M)$77.5M▲ +852.4%9.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

VREX · P/FCF · FCF yield · FCF per share

Varex Imaging Corporation (VREX) valuation ratios are currently unavailable — market cap, share count, or TTM data could not be retrieved from our data provider.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

Valuation ratios are unavailable — market cap, share count, or TTM data could not be retrieved. Individual metrics are shown where available.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-10-03

Cash flow statement summary

VREX · cash flow statement · operating / investing / financing

For FY2025, Varex Imaging Corporation generated $41.7M in operating cash flow and spent 23M in capital expenditures, yielding $18.8M in free cash flow.

Operating Activities

+$41.7M

Cash from core business operations

2025-10-03

Investing Activities

+$10.3M

CapEx, acquisitions & investments

2025-10-03

Financing Activities

−$75.9M

Buybacks, dividends & debt

2025-10-03

FCF FormulaOperating CF ($41.7M) − |CapEx| (23M) = FCF ($18.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

VREX vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Varex Imaging CorporationYOU

VREX

$18.8M-7.8%2.2%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Varex Imaging Corporation (VREX) reported free cash flow of $18.8M for FY2025 (fiscal year ending 2025-10-03), down 7.8% year-over-year. The FCF margin was 2.2%.

Based on available data, Varex Imaging Corporation has maintained positive free cash flow for at least 11 fiscal year(s). FCF peaked at $95.4M in FY2014.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

VREX free cash flow · 8 questions

Varex Imaging Corporation free cash flow was $18.8M for FY2025, down 7.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$30.8M.

VREX free cash flowVREX FCFVREX FCF 2025VREX free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Varex Imaging Corporation · Varex Imaging Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026